Rock Creek Pharma Revenue, Profits - RCPIQ Annual Income Statement

Add to My Stocks
$0 $0 (0%) RCPIQ stock closing price Sep 19, 2018 (Closing)

Fundamental analysis of RCPIQ stock involves analyzing its financial statements, apart from checking the Rock Creek Pharma stock price. The income statement gives the investor an understanding of the topline or revenue and bottomline or profit numbers of the company and helps investors evaluate if a company has been growing or not. Like any other income statement, the RCPIQ income statement also itemizes revenue/sales, operating expenses, and profits/bottomline for a quarter or year and reflects a YOY revenue decline of 0 when compared to the same period in the past. The operating expenses as shown in the Rock Creek Pharma profit and loss statement for 2015 total to $11.31M. This line item shows that the operating expenses has decreased compared with last year. Also check: Rock Creek Pharma assets and Rock Creek Pharma free cash flow.

View revenue and profit details for latest and last 10 financial years.
show more
View Previous Years
View Next Years
Fiscal year is Jan - Dec20152014201320122011201020092008
Rock Creek Pharma Revenues or Net Sales
Cost Of Goods Sold (COGS)--5.17M3.56M3.4M2.18M2.62M2.12M
Rock Creek Pharma Gross Profit
Research & Development Expense2.48M3.61M2.99M4.55M3.34M3.03M1.79M-
Selling General & Admin Expense8.83M28.96M33.89M22.67M32.74M23.84M19.04M18.76M
Income Before Depreciation Depletion Amortization-11.31M-32.57M-32.92M-24.61M-37.76M-28.21M-22.76M-20.75M
Depreciation Depletion Amortization--------
Non Operating Income4.96M-0.53M-0.3M6.61M---1.05M
Interest Expense--------
Rock Creek Pharma Pretax Income
Provision for Income Taxes--------2.22M
Investment Gains Losses--------
Other Income--------
Income Before Extraordinaries & Disc Operations-6.76M-33.11M-33.22M-18.1M-37.98M-28.28M-22.8M-18.33M
Extraordinary Items & Discontinued Operations-0.08M-5.4M--4.75M----
Rock Creek Pharma Profit/ Loss (Net Income)
Average Shares used to compute Diluted EPS9.72M7.38M6.72M5.88M5.35M4.74M4.08M3.59M
Average Shares used to compute Basic EPS9.72M7.38M6.72M5.88M5.35M4.74M4.08M3.59M
Income Before Nonrecurring Items-6.76M-33.12M-26.68M-25.2M-37.99M-28.28M-22.8M-18.34M
Income from Nonrecurring Items---7.1M----
Rock Creek Pharma Earnings Per Share Basic Net
Rock Creek Pharma Earnings Per Share Diluted Net
EPS Diluted Before Nonrecurring Items-0.70-4.50-4.00-4.25-7.00-6.00-5.50-5.00
Preferred Dividends Acc Pd--------
Dividends Common--------
Dividend Per Share Common0.
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Click here to view our Shire financial analysis

Rock Creek Pharma stock analysis involves checking at least a few of the important things like:

  • Revenue: This is the inflow that is generated from the sale of goods or services and is $- for this year of 2015. Our Rock Creek Pharma revenue chart gives a clear visual representation of how the topline or sales growth has been. Investors often invest only in those companies where the revenue is growing at a steady rate.
  • Bottom line: This refers to the last line in a profit and loss statement and denotes the net profit or loss for a particular period. The figure currently stands at $-6.84M for Rock Creek Pharma for 2015. This figure is arrived at after deducting all operating expenses, interest, and taxes from revenue.

The income statement is also called statement of revenue and expense. The RCPIQ financials along with Rock Creek Pharma historical stock prices provide a lot of details about the firm.

Rock Creek Pharma Income Statement - Key Financial Ratios

Annual Income Statements - Rock Creek Pharmaceuticals Inc Industry Peers

China BCT income statement, Poniard Pharma income statement, Shire income statement